Michael Robert Martin, Chief Business Officer at Aurinia Pharmaceuticals Inc. (AUPH), sold 9,698 shares at $12.01 ($116K) on 2022-03-02, disclosed to the SEC on 2022-03-04.
Open-market sale of $116k AUPH by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.01 | 4,849 | $58K | 50.0% |
| 2 | $12.01 | 4,849 | $58K | 50.0% |
| Total | $12.01 avg | 9,698 | $116K | 100% |
| Filing → |
| AUPH | SELL | 2021-11-03 | $1.4M | — | Filing → |
| AUPH | SELL | 2021-09-22 | $2.7M | — | Filing → |
| AUPH | SELL | 2021-09-16 | $958K | — | Filing → |